NASDAQ · Financial Statements

Belite Bio, Inc (BLTE) Financial Statements

$157.14 NASDAQ: BLTE Market Cap $6.30B

Belite Bio, Inc most recently reported annual revenue of $0, net profit of $-78.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-10.0M$-13.0M$-32.0M$-40.0M$-84.0M
Net Profit$-10.0M$-13.0M$-32.0M$-36.0M$-78.0M
EPS$-0.40$-0.63$-1.19$-1.18$-2.31
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$18.0M$44.0M$95.0M$152.0M$781.0M
Total Liabilities$33.0M$3.0M$4.0M$6.0M$10.0M
Cash$17.0M$42.0M$88.0M$32.0M$353.0M
Borrowings$32.0M$1.0M$1.0M$1.0M$0

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-7.0M$-11.0M$-30.0M$-29.0M$-37.0M
Investing Cash Flow$0$-1.0M$0$-111.0M$-305.0M
Financing Cash Flow$0$-1.0M$-1.0M$41.0M$370.0M
Net Cash Flow$-8.0M$25.0M$46.0M$-56.0M$321.0M
Free Cash Flow$-8.0M$-12.0M$-30.0M$-29.0M$-37.0M

Valuation & Return Ratios

MetricValue
PEG Ratio1.15
EV / EBITDA-65.90
FCF Yield-0.00%
Quick Ratio33.71
Interest Coverage0.00
Return 1Y135.19%
Return 3Y314.08%
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
BLTE Overview BLTE Dividend Run Stock Screener